Your membership is expired. Please renew your membership to login. | Renew memberhip
If using IE11, please consider using an alternative browser.
Not a Member? In order to develop the most comprehensive beneficial standards for the healthcare industry we gather input, expertise, advocacy & leadership from our NCPDP members. Become a Member
NCPDP webinars provide timely insight on critical healthcare business issues, compliance with ever-changing healthcare regulations, and successful implementation of NCPDP standards to realize their full benefit. Available at a discounted price to members, our webinars typically offer CE hours for pharmacists and pharmacy technicians and focus on the hot topics within the industry.
Continuing Pharmacy Education (CPE) credits for pharmacists and pharmacy technicians are provided for select Webinars thanks to a sponsorship by CoverMyMeds.
Unless noted as complimentary, webinar pricing is as follows:
NCPDP Members: $50 per Webinar
Non-Members: $150 per Webinar
NCPDP/HIMSS Town Hall webinars are complimentary webinars available to NCPDP members and non-members.
Please check back frequently to see an updated list of upcoming Live Webinars.
Get an end-of-year legal update on some of the newest laws and regulations that affect pharmacy benefit managers (PBMs), pharmacies, plans, and others involved in the prescription benefit industry.
You don’t want to miss the latest details from the Federal Trade Commission Inquiry into PBMs and key highlights of the PBM Transparency Acts of 2022 and 2023, plus other related legislation at the federal level presented by The Phoenix Law Group, PLC.
The Phoenix Law Group, PLC, will focus on which entities the proposed requirements cover and apply to, as well as key provisions and differences between the various pieces of legislation.
Phoenix Law Group, PLC
Phoenix Law Group, PLC
Digital therapeutics (DTx) involves health software generating and delivering a medical intervention with a demonstrable positive therapeutic impact on a patient’s health. As DTx grows to become more integral to healthcare, it is important to align on taxonomy and policy initiatives to support responsible innovation and adoption.
This webinar will highlight key updates to the definition and framework of digital therapeutics in 2023, as well as examine the policy history and landscape shaping the field today. We’ll also explore the outlook and opportunities to collaborate on future policy to enable patient access while ensuring efficacy and safety. Attendees will be well-versed in the latest digital therapeutics terminology, policy context, and path forward as we drive improved outcomes through evidence-based virtual care integration.
Andy Molnar, Chief Executive Officer, Digital Therapeutics Alliance (DTA)
Lani Hessen, Vice President Patient Access, Digital Therapeutics Alliance (DTA)
Sara Elalamy, Director of U.S. Government Affairs, Digital Therapeutics Alliance (DTA)
Join this important webinar to learn about industry feedback and recommendations from NCPDP‘s MC Standards Message Structure Harmonization (SMaSH) Task Group on how best to move into a future with modernized NCPDP standards formats.
Leyla Rahjou-Esfandiary, Pharm. D.
Team Lead, Data Quality and Compliance Team Drug Registration and Listing Branch (eDRLS) Office of Compliance, Center for Drug Evaluation and Research U.S. Food and Drug Administration
As the understanding and value of pharmacogenomics (PGx) continue to evolve and be increasingly recognized, solutions must be implemented to enable the long-term utility and mobility of patients’ data. This presentation will introduce PGx and its relevance to personalized healthcare and solutions for effective application, using clinical content and real-world case studies, while describing the needs and solutions for interoperability with pharmacogenomics across the healthcare industry.
The panelists will explore the benefits of evidence-based medication management versus the treatment-as-usual approach and explain why testing is important to putting personalized healthcare into practice. Plus, learn how NCPDP’s Foundation is helping enhance the integration of genetic data into the pharmacy workflow today!
Digital therapeutics (DTx) have evolved over the last decade to enhance the patient experience across many different disease categories. Software can now be used to directly deploy interventions to treat, manage or prevent symptoms of diabetes, anxiety, PTSD, circulatory and respiratory disease among others. This session will provide an overview of digital therapeutics and their position in the healthcare ecosystem. Participants will gain an understanding of digital therapeutics as they differ from mobile health apps. Additionally, our subject matter experts will cover how these products are brought to market, reimbursed and reach the patient populations they will benefit.
Meet the Speakers:
Andy Molnar, Chief Executive Officer, Digital Therapeutics Alliance (DTA)
Lani Hessen, Vice President of Patient Access, Digital Therapeutics Alliance (DTA)
Join this live online learning event featuring The Phoenix Law Group with an update on the newest laws and regulations that affect PBMs, pharmacies, plans, and others involved in the prescription benefit industry, including the Consolidated Appropriations Act (CAA).
This webinar will also cover the U.S. Supreme Court decision that overturned Roe v. Wade, subsequent guidance issued by the Biden Administration, and the current status of state laws restricting access to medication abortion. The presentation will specifically address application of federal laws and guidance to state restrictions on abortion, including the just-issued conflicting court decisions in Texas and Idaho, and strategies for pharmacies, PBMs, and health plans to stay in compliance with the applicable laws.
Meet the Speakers:
Cami Agena, Partner, Phoenix Law Group
Laurel Wala, Partner, Phoenix Law Group
Join us for the webinar NCPDP Pharmacy Standards – HIPAA Updates to gain a comprehensive overview of important changes made to Telecommunication Version F6 and the Batch and Subrogation Standards. By attending this session, you will learn about critical revisions in Telecommunication Version F6 that include modifications to the DUR/PPS Response Segment, updates to the Request Patient Segment and Response Patient Segment, a new Response Provider Segment, new Response Claim segment field, and more. Plus, benefit from knowing the new Batch Standard updates like the Transaction Reference Number length increase, clarified use of multiple entity types, example modifications, and FAQs. And deepen your understanding of the Subrogation Implementation Guide changes that will help meet compliance requirements, reduce manual processes, support a new uniform approach to claims, achieve payment accuracy and support cost containment.
NCPDP is continuously reviewing and updating the three standards to improve workflows and reduce errors in data collection. Hundreds of requested changes were incorporated into these standards that will be used by payers and processors to support pharmacy claims processing, eligibility verification, predetermination of benefits, prior authorization and information reporting. The goal is to optimize communication between payers, providers, and patients to ensure patient safety, better medication adherence and improved access to care.
Margaret Weiker, Vice President, Standards Development, NCPDP
As part of the NCPDP HIMSS Pharmacy Town Hall series, this webinar presented by the U.S. Food and Drug Administration (FDA) gives an overview of the scientific concepts about biological products and the scientific and regulatory basis for the biosimilar and interchangeable biosimilar approval pathway. It explores the science of biological molecules, including size, complexity, and structure, plus reviews practical information regarding the use of these products, such as labeling, terminology, and pharmacy substitution. It also demonstrates the functionality of the Purple Book Database and shares what FDA educational materials are available for healthcare professionals and patients.
Nina Brahme, Ph.D., M.P.H., Scientific Reviewer, U.S. Food and Drug Administration (FDA)
Shelley Skibinski, Pharm.D., Project Coordinator, U.S. Food and Drug Administration (FDA)
Sarah Ikenberry, M.A., Senior Communication Advisor, U.S. Food and Drug Administration (FDA)
In March of 2021, the NCPDP Foundation funded an effort to migrate the NCPDP Telecommunication standard to a syntax consistent with current technology. Working closely with NCPDP staff, the WG1 Telecommunication Agility Next Generation (TANG) Task Group members and members of WG1 Telecommunication, JSON was selected. The outcome of this project is a JSON representation of the Telecommunication Standard Version F6 content in a way that is supported by current tooling and skill sets. Needs identified by NCPDP members, such as extensibility have been added. In addition, for alternative connectivity protocols and enhanced security options are possible.
Watch this on demand video to learn key areas of the project: stakeholder engagement, analysis of options available, the development and testing approach, and finally, information about the model itself.
After this educational session, attendees will be able to:
Frank McKinney, Senior Consultant, Point of Care Partners
There is a growing demand in the market for consumer-directed information and cost transparency. This is one of the few policy agenda items in Congress that has bipartisan support. Efforts are underway to allow patients to download their records and also to use mobile technology to check out-of-pocket costs for their prescription medications. But opening up data to consumers can pose challenges including how to address patient consent issues, security and privacy of patient data, and the potential for consumers to not fully understand the information they are viewing. This session will highlight industry accomplishments, challenges and opportunities for consumer-facing applications.
If you are an NCPDP member, please contact Brian Goerlich for access to this webinar.
This session will provide an update on the newest laws and regulations that affect PBMs, pharmacies, plans, and others involved in the prescription benefit industry. The update will include such laws as pricing transparency, any willing provider and steerage, credentialing, provider mandates and contracting, MAC, pharmacy audits, discount cards, benefit mandates, licensing and utilization management, among others.
The latest update to the future format of NDC and the circumstances under which listing data is inactivated by FDA will be discussed in this session.
When patients or caregivers administer oral liquid medications, they rely on the dosing instructions on the medication container labels to be clear and consistent with an appropriate dosing instrument. Otherwise, administration errors, overdoses and underdoses may result. In 2014, NCPDP released “Recommendations and Guidance for Standardizing Dosing Designations on Prescription Container Labels of Oral Liquid Medications”. These recommendations catalyzed further prescriber recommendations; manufacturing guidelines; and e-prescribing software certification standards. This session will discuss updated NCPDP Recommendations based on new error-prevention research and lessons learned from the 2014 Recommendations in order to continue to improve patient safety and patient outcomes.
Blockchain technology can play a large role in the future of pharmacy. What could it look like? Join Milliman experts, Brian Anderson, Greg Callahan, and Michael DiPrima as they discuss the potential of blockchain technology in the pharmacy/PBM/payer space. This session will tackle what blockchain technology is, why it is important in healthcare, and why it could be the future of pharmacy.
The proliferation of layouts, approaches, standards and a lack of open source implementations is holding back interoperability in healthcare. By embracing open source software, we can improve interoperability and save money. Learn how this approach can clarify thinking and reconcile ambiguities in the standards making process while also helping to drive rapid adoption of updates and new standards.
Doug Long, VP Industry Relations for IQVIA, will give his highly anticipated IQVIA™ Market Trends Report. which features trends and forecasts of the U.S. market. Wholesalers, retailers, manufacturers, and multiple trade associations rely on the IQVIA Market Trends Report for guidance, direction and industry expertise.
IQVIA is the world’s largest pharmaceutical information company and provides consulting services and an extensive product portfolio to the pharmaceutical industry in more than 101 countries worldwide. Since joining IQVIA (formerly IMS) in 1989, Doug has been active in the successful implementation of data health databases and has a unique perspective on the changing U.S. and global healthcare marketplace and pharmaceutical distribution. He is a frequent industry speaker and is a permanent member of the Editorial Advisory Board of HealthCare Distributor magazine. He was a recipient of the 2004 Nexus Award for Lifetime Achievement and IMS’ prestigious Summit Award in 2003.
Across industry and government, 2019 was the year of Real Time Benefit Tools (RTBT). On May 16, 2019, the Centers for Medicare & Medicaid Services (CMS) issued its final rule requiring Part D plans to adopt one or more RTBTs by January 1, 2021. NCPDP took on the work of creating a standard and the industry brought these tools into the pharmacy, providing the information to both prescribers and pharmacists. All of these efforts, were undertaken to create an optimal prescription experience for patients.
While healthcare gets a bad rap for slow change, the fundamental foundations of traditional healthcare are being shaken. Big changes, driven by employee consumers, are happening and the question is whether traditional healthcare will adapt in time. Forty-five percent of people under 40 do not identify with a primary care physician and 50% of people want to proactively manage their health through technology. The working age population is driving their own view of how healthcare should be delivered. Virtual care and healthcare consumerism will be a key part of this initiative. How will employers fit this non-traditional healthcare into their benefit plans?
Complex, chronic illnesses – from rheumatoid arthritis to multiple sclerosis – are on the rise. In correlation with an aging population, nearly half of all Americans (45 percent) suffer from at least one chronic disease. The healthcare industry can expect the need for specialty medications and prescribing to grow exponentially. How will specialty prescribing keep up if prescribers and pharmacists are still dependent on faxes and phone calls? The industry is working to streamline specialty prescribing. Learn about what is on the horizon, from regulations to technology innovations.
Today, prescription administration instructions appear on medication labels in an inconsistent manner. The inconsistency or lack of standardization in the instructions makes it hard for patients to understand and adhere to their medication regimens, resulting in adverse drug events and/or less than optimum health outcomes. What’s more – varying levels of health literacy and the increase in patients taking multiple medications compound the complexity of this patient safety issue.
NCPDP’s “Universal Medication Schedule White Paper,” published in 2013, describes the need for the Universal Medication Schedule (UMS) and how it can be implemented using NCPDP’s SCRIPT Standard to simplify prescription administration directions. But how far have we come as industry in addressing this important patient safety issue? This session will explore the best practices and pitfalls that affect medication adherence; research on the current state of UMS; and a path forward to addressing this patient safety issue.
Artificial intelligence (AI) is emerging as a transformational force in health care with global investments projected to exceed $27 billion by 2025, a 44% compounded annual growth rate since 2018. Driving these investments are AI’s potential to improve health outcomes, provide accurate and earlier chronic disease diagnosis and support development of tools for older patients.
This webinar will focus on medication management, highlighting six ways AI is being used today to address persistent problem areas in medication use, and conclude with an interactive discussion focused on identifying and addressing development and implementation barriers. In addition, Ken will define the types of AI being used (predominately machine learning and natural language processing), how models are developed and how attendees can begin to use AI to improve medication management in their organizations.
Challenges aligning medications to coverage, managing controlled substance prescribing, and meeting specialty medications requirements significantly impact speed to therapy. However, standards are breaking down the barriers by bringing the right information into the right point in workflows. Join us at this informative session exploring how standards and innovations are improving electronic transactions, data intelligence, and workflow automation between prescriber and pharmacist and getting must needed therapies to patients quickly.
Advancements in e-prescribing and electronic messaging have improved communication channels between facilities and pharmacies. While at the same time, complexity in the process from prescribing to fulfillment has increased. Logic governing coverage, eligibility, and participation in specialty programs have a lot of dependencies and prone to delaying the delivery of medication therapy to patients.
Three critical focus areas for this presentation include electronic prescribing of controlled substances; enrollment in specialty medication programs; and age-old challenge of simplifying steps the pharmacist and prescriber must take clarify or request a change to a prescription.
The presentation will describe how today’s standards and innovations are getting therapies to patients not in months, but in minutes. Efficiencies occurring in the trenches of care delivery will be discussed along with lessons learned about filling workflow gaps that still exist today.
Ryan Hess, MBA
VP of Product Innovation
Ryan manages multiple businesses under the Enhance Prescribing portfolio. With over a decade of experience in healthcare, he leads innovation for solutions including medication eligibility and formulary, real-time prescription benefit, medication history, and prior authorization solutions. Ryan writes and speaks on how technology and standards enhance workflows across healthcare delivery.
Continuing Pharmacy Education (CPE) credits for pharmacists and pharmacy technicians will be available for this webinar, thanks to a sponsorship by CoverMyMeds.
Director, Regulatory Affairs
Adam Chesler is currently the Director of Regulatory Affairs for Cardinal Health. He has more than 15 years of experience in pharmacy including positions as Vice President of Operations for TelePharm; Director of Strategic Alliances for PTCB; and manager roles with Walgreens and Target. Adam was appointed to the Texas State Board of Pharmacy Task Force on Pharmacy Technician Practice, the Texas E-Health Committee, and has testified before state legislatures in support of advancing the pharmacy profession. He earned a doctorate degree in Pharmacy from the University of Texas and holds a degree in Health Science from the University of Miami.
The implementation of the HITECH Act of 2009 has resulted in a large-scale effort to digitize health data. However, without a Universal Patient Identifier (UPI), data interoperability between all constituents that make up the healthcare marketplace is not feasible. To achieve this interoperability of data, a Universal Patient Identifier that will efficiently and accurately link health data at scale to improve patient safety and reduce mistaken identity involved with medical procedures.
Attend this webinar to learn about the Universal Patient Identifier and current legislative updates, impacts across the industry and how to will improve the healthcare experience for patients and providers.
The healthcare industry is on the verge of something big. Federal initiatives calling for greater transparency in prescription drug costs and industry innovators working to make the critical juncture of diagnosis and treatment easier on patients are converging with the development of an industry standard: the NCPDP Real-Time Prescription Benefit Standard. With the standard comes the potential to completely transform the patient-provider experience, giving prescribers access to patients’ out-of-pocket costs at the point of care for better informed, collaborative decision-making.
This is a boost for prescribers and pharmacists, allowing providers visibility on patients’ eligibility and benefit information within existing workflows through EHRs and other ePrescribing systems. The BETA Version of the NCPDP Standard, available in both XML and EDI formats, was approved in August 2019 and is set to go to ballot mid-September.
John Klimek, R.Ph.
In June 2018, CMS adopted a three-pronged approach to address prevention and treatment of opioid addiction within the Medicare community, which led to the development of a series of Opioid Overutilization Initiatives designed to stem over prescribing of opioid pain medications. In response to these new rules, which took effect January 1, 2019, NCPDP provided new guidance in its Telecommunication Version D and Above Questions, Answers and Editorial Updates document to illustrate how to use the Telecommunication Standard’s transactions to properly prescribe opioids based on these new rules.
Using the opioid-specific scenarios offered in the Editorial Updates document, this webinar will help plans, payers and providers -- especially state Medicaid and fiscal agents -- understand how morphine milligram equivalent (MME) dosing requirements can be standardized for a more systematic approach for handling rejections and responses throughout the industry, streamlining the customer experience and improving patient safety.
Michele V. Davidson, R.Ph., Senior Manager, Pharmacy Technical Standards, Development & Policy, Government Relations, Walgreen Co.
Kelley Vaughan, Director, Claims Service Operations, MedImpact
By 2020, a projected 9 out of 10 top-selling drugs by revenue will be Specialty. The current process for exchanging data, including prescription data, regarding specialty medications is complex and manual, taking days to weeks to begin a patient on therapy. This webinar will provide insight on the patient experience and guidance on how to become involved in creating solutions to improve care for Specialty patients. The webinar will include an overview of the current Specialty pharmacy process; highlight electronic transactions available to improve patient care; and provide guidance on how to become involved in future enhancements.
Continuing Education Credits for pharmacists and pharmacy technicians will be available for this webinar.
Part 3 of the complimentary NCPDP/HIMSS Town Hall Series, is sponsored by Surescripts.
Important standards work is being done to facilitate medication cost transparency and workflow efficiency across healthcare stakeholders: prescribers, pharmacies, payers/PBMs, and patients. Co-leads of NCPDP’s Real Time Prescription Benefit Standard Task Group, Roger Pinsonneault, R.Ph., Vice President, Product Innovation, Gemini Health, and Tim McNeil, NSC, Director, Standards, Surescripts, will provide updates on work related to the national standards for cost transparency, and provide practical examples of the impact the standards are having within care delivery. They will also share insights on future innovations in cost transparency.
Sponsored by Surescripts
Roger Pinsonneault, R.Ph.
Tim McNeil, NSC
Regardless of where your organization is in its planning, we invite you to bring your questions and attend this webinar dedicated to getting you on the path to a successful implementation.
As the industry prepares for the January 1, 2020 implementation date for SCRIPT v2017071, many ePrescribing vendors have started devising their product update plans. Regardless of where your organization is in its planning, we invite you to bring your questions and attend this webinar dedicated to getting you on the path to a successful implementation.
Attend this webinar to:
Ashley H. Maples CPhT NSC
Tim McNeil, NSC
Tolu Akinwale R.Ph. MBA PharmD
Learn more about how NCPDP’s SCRIPT Standard is developed and how Extensible Markup Language, or XML, is used in ePrescribing standards. Join NCPDP Technical Analysts, Teresa Strickland and Paul Wilson, to learn how to view, read and interpret XML in ePrescribing standards.
Attendees will learn:
Paul Wilson, NCPDP Technical Analyst, Standards Development
Teresa Strickland, NCPDP Technical Advisor, Model Facilitator, Standards Development
Join NCPDP members Mary Perez, Medicare Part D Senior Systems Analyst, Enrollment with Magellan Rx Management, and Nancy Bridgman, Director of Medical Billing with Remedi SeniorCare, as they explain Medicare Part D’s impact on the hospice patient.
Attendees of the webinar will:
This session will provide the current status of e-prescribing including a regulatory update, identify key opportunities to improve electronic prescription accuracy, and share the results of how those opportunities are being addressed through specific initiatives targeting SIG and drug description. Additionally, the session will showcase the NCPDP SCRIPT standard-based RxChange and CancelRx transactions and the role they play in driving improved patient safety.
Continuing Pharmacy Educations (CPE) units will be available for pharmacists and pharmacy technicians. Sponsored by Surescripts.
Ken Whittemore Jr., R.Ph., MBA
Stacy Ward-Charlerie, PharmD
Thomas Agresta MD, MBI
After attending the webinar, you will understand:
Lynnae Mahaney, B.S., Pharm., MBA, FASHP
The On-Demand Webinar recording will include a recap of the recent Unique Device Identifier (UDI) system history, a summary of the changes device manufacturers are implementing, information from the FDA UDI regulation and its subsequent guidance document. Links to critical resources will be shared.
Upon successful completion of this activity, pharmacists should be able to:
Melva Chavoya, Clinical Database Manager, Walgreen Co.
Dennis Black, Director, e-Business, Solutions GroupBecton Dickinson
Terrie L. Reed, Senior Advisor Office of Surveillance and Biometrics, FDA Center for Devices and Radiological Health (CDRH)
NCPDP’s Elite Partners provide the highest level of support for the valuable work of NCPDP in advancing patient safety and interoperability. The following Elite Partners have demonstrated intense commitment to support NCPDP’s work, vision and core values.